All In Biotech

Drug Trial Radar · NCT05059327

Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSC

A Phase 2B, Multicenter, 30-week, Prospective, Cross-over, Double-blind, Randomized, Placebo-controlled Study Followed by a 52-Week Open-label Extension Study to Evaluate the Efficacy and Safety of Basimglurant Adjunctive to Ongoing Anticonvulsive Therapy in Children, Adolescents, and Young Adults With Uncontrolled Seizures Associated With Tuberous Sclerosis Complex

Last checked: Nov 19, 2026Latest source record: Jun 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

61

Actual

Start

Mar 3, 2022

Primary completion

Feb 6, 2025

Study completion Apr 28, 2025

Sponsor

Lead sponsor
Noema Pharma AGIndustry
Sponsor type
Industry
First posted
Sep 28, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Crossover
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 5 years, up to 30 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study intends to show that basimglurant (NOE-101) provides effective seizure control in children, adolescents and young adults with Tuberous Sclerosis Complex (TSC).

Conditions

  • Tuberous Sclerosis Complex

Interventions

  • Basimglurant with crossover to PlaceboDrug

    Basimglurant with crossover to Placebo

  • Placebo with crossover to BasimglurantDrug

    Placebo with crossover to Basimglurant

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean percentage in monthly seizure frequency during the maintenance dosing in Period 2 (Weeks 13 to 16) and Period 4 (Weeks 27-30).Time frame: 30 weeks

Locations

27 sites in 8 countries. Site status is shown where the registry gives one.

  • David Geffen School of Medicine at UCLA (Site #: 101)

    Los Angeles, California

  • Kennedy Krieger Institute (Site #: 110)

    Baltimore, Maryland

  • Boston Children's Hospital (Site #: 102)

    Boston, Massachusetts

  • William Beaumont Hospital - Royal Oak (Site #: 104)

    Royal Oak, Michigan

  • Minnesota Epilepsy Group PA (Site #: 105)

    Roseville, Minnesota

  • Boston Children's Health Physicians (BCHP) (Site #: 111)

    Hawthorne, New York

  • Duke Children's Hospital and Health Center (Site #: 106)

    Durham, North Carolina

  • University Hospitals Cleveland Medical Center, Rainbow Babies and Childrens Hospital (Site #: 107)

    Cleveland, Ohio

  • The University of Texas Medical School at Houston (Site #: 103)

    Houston, Texas

  • Citi Neuro Centre (Site # 806)

    Hyderabad, Andhra Pradesh, India

  • Rainbow Childrens Hospital (Site # 803)

    Hyderabad, Andhra Pradesh, India

  • Jaslok Hospital and Research Centre (Site # 801)

    Mumbai, Maharashtra, India

  • Deenanath Mangeshkar Hospital and Research Centre (Site # 805)

    Pune, Maharashtra, India

  • All India Institute of Medical Sciences (Site # 804)

    New Delhi, National Capital Territory of Delhi, India

  • Christian Medical College (Site # 807)

    Vellore, Tamil Nadu, India

  • Hadassah Medical Center - PPDS (Site #: 503)

    Jerusalem, Israel

  • ASST Grande Ospedale Metropolitano Niguarda - Presidio Ospedaliero Ospedale Niguarda (Site # 183)

    Milan, Lombardy, Italy

  • Instytut Pomnik Centrum Zdrowia Dziecka (Site # 262)

    Warsaw, Masovian Voivodeship, Poland

  • Hospital Regional Universitario de Malaga - Hospital General (Site # 193)

    Málaga, Spain

  • Centro de Neurología Avanzada (Site # 191)

    Seville, Spain

  • Hospital Universitario Germans Trias i Pujol (Site # 194)

    Badalona, Barcelona, Spain

  • Hospital Sant Joan de Deu - PIN (Site # 192)

    Esplugues de Llobregat, Barcelona, Spain

  • Istanbul Universitesi Istanbul Tip Fakultesi Hastanesi (Site #: 905)

    Fatih, Istanbul, Turkey (Türkiye)

  • Yeditepe University Kosuyolu Hospital (Site #: 904)

    Kadıköy, Istanbul, Turkey (Türkiye)

  • Istanbul Egitim ve Arastirma Hastanesi (Site #: 901)

    Sultangazi, Istanbul, Turkey (Türkiye)

  • Salford Royal Hospital - PPDS (Site # 304)

    Salford, Lancashire, United Kingdom

  • Noahs Ark Children's Hospital (Site # 306)

    Cardiff, South Glamorgan, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.